@Immunexpress profile picture
Immunexpress @Immunexpress

Immunexpress is a privately-held molecular diagnostic company committed to improving outcomes for patients with, or at risk of, sepsis.

Joined August 2012
  • Tweets 1,236
  • Following 605
  • Followers 322
721 Photos and videos
Immunexpress is presenting at #SCCM 2026, showcasing data on SeptiCyte RAPID®, including strong correlation with blood culture–positive sepsis (91%) and results in ~1 hour. Chicago | Booth #642 March 22–24 prn.to/4t3wwCq
34
New publication in the European Journal of Haematology demonstrates that SeptiCyte RAPID® differentiates infection from sterile inflammation in bone marrow transplant patients with febrile neutropenia. Read more here: prn.to/4rCr8WA
33
From the team at Immunexpress, wishing everyone a safe and happy Thanksgiving holiday!
10
The 9th Annual National Hospitalist Conference is just around the corner in Clearwater Beach, Florida from December 1-4! We hope to see you there. If you are attending, visit our booth! Learn more here: hospitalistconference.org/ #HospitalMedicine #MedicalEducation #PatientCare
16
Flu season is here, and the flu can sometimes lead to serious infections which can escalate into life-threatening complications such as #sepsis, a medical emergency. Know the warning signs of sepsis, as early recognition saves lives. Learn more here: endsepsis.org/2023/12/31/flu…
19
Two-thirds of #sepsis cases affect adults over 60 and can begin with an infection, a wound, or an invasive device like a feeding tube. Older adults face higher risk and every hour of delayed treatment increases the risk of death by 8%. Learn more here: bit.ly/4pfteKj

Sepsis - Alliance for Aging Research

Every year more than 1.7 million Americans develop sepsis—a life-threatening medical condition that happens when the body overreacts to an infection from a bacteria, virus, parasite or fungus,...

agingresearch.org
11
We are excited to share that our team will be attending the 9th Annual National Hospitalist Conference in Clearwater Beach from December 1-4! If you are attending, visit our booth! Learn more here: bit.ly/4oZI5Z5 #HospitalMedicine #MedicalEducation #PatientCare
16
The #GBD2021 study shows sepsis remaining a leading cause of death worldwide, responsible for 31.5% of deaths in 2021, highlighting an urgent need for infection prevention, early recognition, and chronic disease management. Read the full publication: bit.ly/4oBw38F
12
Early and accurate sepsis diagnosis must work for all patients, but the signs and responses to infection can vary widely. SeptiCyte® RAPID has been clinically validated across patient groups and in heterogeneous patient populations. Learn more here: bit.ly/4oQf2an
9
Increasing awareness about #sepsis, and sustained efforts to improve healthcare infrastructure and technologies available for sepsis diagnosis, such as SeptiCyte® RAPID, is driving the expansion of the sepsis diagnostics market. Read more here: bwnews.pr/4oRSHZV
0:05
13
Sepsis starts with an infection. But when the body’s response spirals out of control, it can become life-threatening within hours. Learn more here: bit.ly/4odHraD Early recognition and treatment are critical to survival. #SepsisAwareness #PatientSafety
0:05
27
Early #sepsis recognition saves lives, especially among high-risk groups including diabetics. SeptiCyte® RAPID has demonstrated effectiveness in quickly diagnosing #sepsis in hyperglycemic patients. Read more here: bit.ly/4qrRjio
9
Fast and accurate diagnostics tools such as SeptiCyte® RAPID can help clinicians make better decisions and address the threat of antimicrobial resistance in #sepsis treatment. Learn more here: bit.ly/4btJ4tV
13
Immunexpress today announced publications of two articles in the @IJMS_MDPI and @JCriticalCare that demonstrated the clinical utility of SeptiCyte® RAPID for #sepsis diagnosis in critically ill surgical patients. Read here: bit.ly/49gc0rp & bit.ly/4qn4ot8
1
22
SeptiCyte® RAPID uses a novel immune response signature to quickly differentiate sepsis from non-infectious systemic inflammation, and is the only FDA-cleared molecular lab-based test for sepsis. Learn more here: septicyte.com/ #Diagnostics #MedicalTechnology
9
Sepsis progresses in hours, but commonly employed diagnostic tools take far too long to give a result. To keep pace with this life-threatening condition, we developed SeptiCyte® RAPID, with actionable results ready in about an hour. Learn more here: septicyte.com/
1
26
Sepsis often goes unrecognized until it is too late. Current diagnostic tools lag behind the speed at which #sepsis progresses, leaving doctors without the answers they urgently need. Innovation in sepsis detection is an imperative for patients. #SepsisAwareness #Diagnostics
15
The 2025 @SCCM Florida Chapter Annual Symposium was a great opportunity to connect with colleagues, learn from the latest innovation, and contribute to the important discussions shaping the future of critical care. See you next year! #CriticalCare #SCCM
18
We are excited to share that our team will be attending the 2025 @SCCM Florida Chapter Annual Symposium from October 3-4. If you are attending, visit our booth! Learn more here: floridasccm.com/annual-sympo… #CriticalCare #SCCM

Annual Symposium - Florida Chapter Society of Critical Care Medicine

floridasccm.com
5
As Sepsis Awareness Month concludes, it is important to remember the toll of #sepsis. With more than 350,000 victims in the U.S. every year, sepsis takes a life very 90 seconds. Action is needed on better diagnostics and treatments. Learn more here: bit.ly/2wKH5ka
5
Load more